Top compounds associated with response to CTD-3105H18.16


Feature Type Standardized
Nominal ANOVA
mRNA AA-COCF3 CTRPv2 pan-cancer AAC 0.043 0.3
mRNA BRD-K64610608 CTRPv2 pan-cancer AAC 0.047 0.3
mRNA BRD-A05715709 CTRPv2 pan-cancer AAC -0.067 0.3
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.045 0.3
mRNA BRD-K29313308 CTRPv2 pan-cancer AAC 0.044 0.3
mRNA PF-3758309 CTRPv2 pan-cancer AAC -0.05 0.3
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.041 0.3
mRNA RG-108 CTRPv2 pan-cancer AAC 0.042 0.3
mRNA BRD-K02492147 CTRPv2 pan-cancer AAC 0.047 0.3
mRNA lenvatinib CTRPv2 pan-cancer AAC 0.043 0.3
Download CSV